Virginia Retirement Systems’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$463K	Buy	20,119 +6,350	+46%	+$209K	﹤0.01%	775
2025 Q3	$414K	Sell	13,769 -5,900	-30%	-$177K	﹤0.01%	783
2025 Q2	$715K	Sell	19,669 -300	-2%	-$10.8K	﹤0.01%	672
2025 Q1	$723K	Buy	+19,969	New	+$831K	0.01%	651
2023 Q3	$510K	Buy	14,300 +3,500	+32%	+$139K	0.01%	691
2023 Q2	$498K	Buy	10,800 +900	+9%	+$41.7K	﹤0.01%	719
2023 Q1	$397K	Buy	9,900 +4,300	+77%	+$185K	﹤0.01%	807
2022 Q4	$259K	Sell	5,600 -500	-8%	-$19.7K	﹤0.01%	1007
2022 Q3	$253K	Buy	+6,100	New	+$313K	﹤0.01%	991
2022 Q1	$763K	Sell	10,500 -3,400	-24%	-$237K	0.01%	731
2021 Q4	$1.17K	Buy	13,900 +1,600	+13%	+$130K	0.01%	617
2021 Q3	$1.11M	Buy	12,300 +2,100	+21%	+$190K	0.01%	580
2021 Q2	$973K	Sell	10,200 -200	-2%	-$20.8K	0.01%	659
2021 Q1	$1.18M	Buy	10,400 +1,800	+21%	+$245K	0.01%	597
2020 Q4	$1.19M	Buy	8,600 +4,800	+126%	+$569K	0.01%	553
2020 Q3	$312K	Buy	3,800 +1,000	+36%	+$82.9K	﹤0.01%	918
2020 Q2	$219K	Buy	+2,800	New	+$185K	﹤0.01%	1015